(Q35164047)

6 August 2017

Involvement of Maillard reactions in Alzheimer disease (English)

1 reference

6 August 2017

0 references

4

1 reference

6 August 2017

5

Mark A Smith

1 reference

6 August 2017

3

Craig S Atwood

1 reference

6 August 2017

2

Mark E Obrenovich

1 reference

6 August 2017

V Prakash Reddy

1

1 reference

6 August 2017

1 May 2002

1 reference

6 August 2017

19

1 reference

inferred from page(s)

published in

Neurotoxicity Research

1 reference

6 August 2017

4

1 reference

6 August 2017

3

1 reference

6 August 2017

191-209

1 reference

https://scigraph.springernature.com/pub.10.1080/1029840290007321

6 August 2017

0 references

cites work

Impairment of the ubiquitin-proteasome system by protein aggregation

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced glycation modification of Rosenthal fibers in patients with Alexander disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

The role of the Maillard reaction in other pathologies: Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Investigations on oxidative stress and therapeutical implications in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Novel approaches to the analysis of the Maillard reaction of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Renoprotective effects of a novel inhibitor of advanced glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

N(delta)-(5-hydroxy-4,6-dimethylpyrimidine-2-yl)-l-ornithine, a novel methylglyoxal-arginine modification in beer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Identification of advanced glycation end products of the Maillard reaction in Pick's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

An immunochemical study on tau glycation in paired helical filaments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced glycation end products: a highly complex set of biologically relevant compounds detected by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Cross-linking of proteins by Maillard processes--characterization and detection of a lysine-arginine cross-link derived from D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Age-dependent accumulation of advanced glycosylation end products in human neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Sugar-mediated crosslinking of alpha-biotinylated-Lys to cysteamine-agarose support: a method to isolate Maillard Lys-Lys-like crosslinks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Progress of the Maillard reaction and antioxidant action of Maillard reaction products in preheated model systems during storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

A tombstone in Alzheimer's?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Role of fructose in glycation and cross-linking of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Structure of advanced Maillard reaction products and their pathological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Early glycoxidation damage in brains from Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Scavenging of Active Oxygen Species by Glycated Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Novel inhibitors of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Free Radical Formation from Secondary Amines in the Maillard Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

The early glycation products of the Maillard reaction: mass spectrometric characterization of novel imidazolidinones derived from an opioid pentapeptide and glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Increasing neurite outgrowth capacity of beta-amyloid precursor protein proteoglycan in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Analysis of N-glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Increased lipoprotein oxidation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

The biology of the receptor for advanced glycation end products and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Evidence against increased glycoxidation in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Early AGEing and Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Is amyloid beta-protein glycated in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Glycosylation of microtubule-associated protein tau in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Neurotoxicity of advanced glycation end-products for cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Role of the Maillard reaction in diabetes mellitus and diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Protein glycation, diabetes, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Distribution of advanced glycation end products in the cerebellar neurons of dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Chromatographic quantification of argpyrimidine, a methylglyoxal-derived product in tissue proteins: comparison with pentosidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Formation of reactive intermediates from Amadori compounds under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Advanced Maillard Reaction End Products, Free Radicals, and Protein Oxidation in Alzheimer's Diseasea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1029840290007321

Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments

21 January 2018

1 reference

12 December 2020

[Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms--new results of clinical studies]

1 reference

12 December 2020

4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

1 reference

12 December 2020

Analysis of microtubule-associated protein tau glycation in paired helical filaments.

1 reference

12 December 2020

Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal

1 reference

12 December 2020

LC/MS Analysis and Antioxidative Efficiency of Maillard Reaction Products from a Lactose−Lysine Model System

1 reference

12 December 2020

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

1 reference

12 December 2020

RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease

1 reference

12 December 2020

beta-carbolines that accumulate in human tissues may serve a protective role against oxidative stress

1 reference

12 December 2020

Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct

1 reference

12 December 2020

Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis

1 reference

12 December 2020

Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal

1 reference

12 December 2020

Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo

1 reference

12 December 2020

Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease

1 reference

12 December 2020

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation

1 reference

12 December 2020

Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction

1 reference

12 December 2020

Free radicals in Alzheimer's dementia: currently available therapeutic strategies

1 reference

12 December 2020

Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process

1 reference

12 December 2020

beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1.

1 reference

12 December 2020

Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo

1 reference

12 December 2020

A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide.

1 reference

12 December 2020

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

1 reference

12 December 2020

Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo

1 reference

12 December 2020

Cross-linking of proteins by Maillard processes: characterization and detection of lysine-arginine cross-links derived from glyoxal and methylglyoxal

1 reference

12 December 2020

Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products

1 reference

12 December 2020

Synthesis of hexose-related imidazolidinones: novel glycation products in the Maillard reaction

1 reference

12 December 2020

Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors.

1 reference

12 December 2020

The presence of a glucose-derived Maillard reaction product in the human lens

1 reference

12 December 2020

Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide

1 reference

12 December 2020

Glycoxidative modification of AA amyloid deposits in renal tissue

1 reference

12 December 2020

Cell-associated pentosidine as a marker of aging in human diploid cells in vitro and in vivo

1 reference

12 December 2020

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide

1 reference

12 December 2020

First evidence for accumulation of protein-bound and protein-free pyrraline in human uremic plasma by mass spectrometry

1 reference

12 December 2020

3-deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone

1 reference

12 December 2020

Protein Aging by Carboxymethylation of Lysines Generates Sites for Divalent Metal and Redox Active Copper Binding: Relevance to Diseases of Glycoxidative Stress

1 reference

12 December 2020

Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?

1 reference

12 December 2020

Pentosidine: A molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia

1 reference

12 December 2020

Aging of proteins: immunological detection of a glucose-derived pyrrole formed during maillard reaction in vivo

1 reference

12 December 2020

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

12 December 2020

Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis

1 reference

12 December 2020

Cross-linking of proteins by Maillard processes--model reactions of D-glucose or methylglyoxal with butylamine and guanidine derivatives

1 reference

12 December 2020

Identification and quantitation of N-(carboxymethyl)valine adduct in hemoglobin by gas chromatography/mass spectrometry

1 reference

12 December 2020

Oxygen is not required for the browning and crosslinking of protein by pentoses: relevance to Maillard reactions in vivo

1 reference

12 December 2020

Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis

1 reference

12 December 2020

Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains

1 reference

12 December 2020

Lipoperoxidation is selectively involved in progressive supranuclear palsy

1 reference

12 December 2020

Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes

1 reference

12 December 2020

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

12 December 2020

6-Deoxy-6-fluoro-L-ascorbic acid: crystal structure and oxidative degradation

1 reference

12 December 2020

Two novel beta-carboline compounds from the Maillard reaction between xylose and tryptophan

1 reference

12 December 2020

CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products.

1 reference

12 December 2020

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

1 reference

12 December 2020

Inhibitory effects of tenilsetam on the Maillard reaction

1 reference

12 December 2020

Identifiers

DOI

10.1080/1029840290007321

1 reference

PubMed ID

12829400

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12829400